This statistic depicts the total aggregate revenues of divestiture candidates among top biopharmaceutical companies as of 2017, by therapeutic area. In oncology, aggregate revenues from divestiture candidates were about **** billion U.S. dollars.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
EY. (January 7, 2019). Total aggregate revenues of divestiture candidates among biopharmaceutical companies as of 2017, by therapeutic area (in billion U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 28, 2026, from /statistics/967739/biopharma-aggregate-revenue-divestitures-by-specialty/
EY. "Total aggregate revenues of divestiture candidates among biopharmaceutical companies as of 2017, by therapeutic area (in billion U.S. dollars)." Chart. January 7, 2019. ÌÇÐÄÆƽâ°æ. Accessed July 28, 2026. /statistics/967739/biopharma-aggregate-revenue-divestitures-by-specialty/
EY. (2019). Total aggregate revenues of divestiture candidates among biopharmaceutical companies as of 2017, by therapeutic area (in billion U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 28, 2026. /statistics/967739/biopharma-aggregate-revenue-divestitures-by-specialty/
EY. "Total Aggregate Revenues of Divestiture Candidates among Biopharmaceutical Companies as of 2017, by Therapeutic Area (in Billion U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 7 Jan 2019, /statistics/967739/biopharma-aggregate-revenue-divestitures-by-specialty/
EY, Total aggregate revenues of divestiture candidates among biopharmaceutical companies as of 2017, by therapeutic area (in billion U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/967739/biopharma-aggregate-revenue-divestitures-by-specialty/ (last visited July 28, 2026)
Total aggregate revenues of divestiture candidates among biopharmaceutical companies as of 2017, by therapeutic area (in billion U.S. dollars) [Graph], EY, January 7, 2019. [Online]. Available: /statistics/967739/biopharma-aggregate-revenue-divestitures-by-specialty/
